Financials
- Market Capitalization 28.41 M
- Employee 29
- Founded 2017
- CEO N/A
- Website www.bioxceltherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00K20GVD2
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.28
ratio cours/chiffre d'affaires
25.81
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4492 | ATNM Actinium Pharmaceuticals, Inc. Common Stock | 0.92 USD | +2.22% | -4.17% | -6.12% | -11.54% | 28.86 M USD | ||
| 4499 | CRVO CervoMed Inc. - Common Stock | 3.07 USD | -0.32% | -10.50% | -25.12% | -59.50% | 28.42 M USD | ||
| 4507 | PSTV PLUS THERAPEUTICS, Inc. - Common Stock | 4.08 USD | -4.67% | +5.43% | -10.53% | +1136.36% | 28.08 M USD | ||
| 4515 | TVRD Tvardi Therapeutics, Inc. - Common Stock | 2.93 USD | -5.48% | -32.33% | +8.92% | -18.61% | 27.49 M USD |